Inside the Quiet Reinvention of Clinical Judgment Calls
May 21, 2026 – 5:10 pm
Image by: Cara
Neurovascular care remains one of the more complex and uncertain areas of modern medicine. Millions live with conditions like intracranial aneurysms without symptoms, yet when an event occurs, the outcomes are often severe, carrying high mortality rates and long-term neurological disability risks.
For neurospecialists, a key challenge is distinguishing between cases that can be safely monitored and those needing intervention before life-threatening events happen. That’s where CARA Systems Inc., a Brooklyn-based NYU spinout, comes in. Led by Co-Founder and CEO Prithvinath Garigapuram, the company has developed a non-invasive clinical decision-support platform integrating AI-driven medical imaging and patient-specific analytics into a unified neurovascular assessment workflow.
The Complexity of Neurovascular Decision-Making
Neurovascular risk assessment relies on interpreting imaging data and understanding patient-specific physiology. Current methods heavily rely on clinical frameworks focusing on factors like size, anatomical location, and demographics but provide limited insights into individual anatomical and hemodynamic characteristics that might influence disease progression. This results in:
- Interpretive variability: Two clinicians reviewing the same case can arrive at vastly different conclusions about severity, rupture risk, urgency, or the need for intervention.
- Escalation to invasive procedures: Uncertainty often leads to escalating toward procedures like digital subtraction angiography, adding costs and operational burdens.
Consolidating Fragmented Information
Garigapuram argues this challenge isn’t unique to neurovascular medicine—it’s prevalent across specialties including oncology, cardiology, and acute care. Crucially, much of the data needed for informed decisions already exists within workflows, but rarely in a form that’s integrated, contextualized, and actionable at the point of care.
The EU tech scene newsletter, curated by our founder Boris, brings you the latest insights, stories from industry experts, and some questionable AI art—all free, every week, in your inbox. [Sign up here](link to sign-up page).